A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)
-
- WADA Atsushi
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- DOKI Noriko
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- OTSUKA Yuki
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- ADACHI Hiroto
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- KONUMA Ryosuke
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- KISHIDA Yuya
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- KONISHI Tatsuya
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- YAMADA Yuta
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- NAGATA Akihito
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- NAGATA Ryohei
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- MARUMO Atsushi
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- NOGUCHI Yuma
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- MUKAE Junichi
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- TOYA Takashi
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- IGARASHI Aiko
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- NAJIMA Yuho
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- KOBAYASHI Takeshi
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- HARADA Hironori
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences
-
- HARADA Yuka
- Clinical Research Support Center, Tokyo Metropolitan Cancer, and Infectious diseases Center Komagome Hospital
-
- SAKAMAKI Hisashi
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
- OHASHI Kazuteru
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
Bibliographic Information
- Other Title
-
- 良好な経過を辿ったt(6;21;8)(p23;q22;q22)を有する急性骨髄性白血病
- リョウコウ ナ ケイカ オ タドッタ t(6;21;8)(p23;q22;q22)オ ユウスル キュウセイ コツズイセイ ハッケツビョウ
Search this article
Description
<p>Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However, the prognosis of AML with variant t (8;21) remains unknown due to the scarcity of reported cases. Herein we report a case of AML with t (6;21;8) (p23;q22;q22). Fluorescence in situ hybridization confirmed a RUNX1-RUNX1T1 fusion signal on the derivative chromosome 8. This is the first report on a variant of t (8;21) involving the breakpoint 6p23. After induction chemotherapy, our patient achieved complete remission and has been stable for four years.</p>
Journal
-
- Rinsho Ketsueki
-
Rinsho Ketsueki 63 (2), 104-107, 2022
The Japanese Society of Hematology
- Tweet
Details 詳細情報について
-
- CRID
- 1390010292560717056
-
- NII Book ID
- AN00252940
-
- ISSN
- 18820824
- 04851439
-
- NDL BIB ID
- 032023655
-
- PubMed
- 35264498
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- KAKEN
-
- Abstract License Flag
- Disallowed
